Wells Fargo & Company Bio N Tech Se Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

A detailed history of Wells Fargo & Company transactions in Bio N Tech Se stock. As of the latest transaction made, Wells Fargo & Company holds 29,720 shares of BNTX stock, worth $3.59 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

29,720

Previous 80,082 62.89%

Holding current value

$3.59 Million

Previous $6.44 Million 45.16%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$78.36 - $124.66 $3.95 Million - $6.28 Million	-50,362 Reduced 62.89%	29,720 $3.53 Million
Q2 2024 Aug 13, 2024	SELL	$80.36 - $102.87 $409,675 - $524,431	-5,098 Reduced 5.98%	80,082 $6.44 Million
Q1 2024 May 10, 2024	BUY	$88.96 - $112.35 $267,680 - $338,061	3,009 Added 3.66%	85,180 $7.86 Million
Q4 2023 Feb 09, 2024	BUY	$90.91 - $112.75 $475,186 - $589,344	5,227 Added 6.79%	82,171 $8.67 Million
Q3 2023 Nov 13, 2023	BUY	$98.5 - $125.08 $653,843 - $830,281	6,638 Added 9.44%	76,944 $8.36 Million
Q2 2023 Aug 15, 2023	BUY	$102.58 - $129.66 $1.32 Million - $1.66 Million	12,839 Added 22.34%	70,306 $7.59 Million
Q1 2023 May 12, 2023	BUY	$122.57 - $153.67 $770,229 - $965,662	6,284 Added 12.28%	57,467 $7.16 Million
Q4 2022 Feb 13, 2023	SELL	$118.43 - $186.05 $1.09 Million - $1.71 Million	-9,179 Reduced 15.21%	51,183 $7.69 Million
Q3 2022 Nov 14, 2022	BUY	$127.65 - $183.11 $891,507 - $1.28 Million	6,984 Added 13.08%	60,362 $8.14 Million
Q2 2022 Aug 12, 2022	SELL	$123.25 - $186.24 $1.61 Million - $2.43 Million	-13,064 Reduced 19.66%	53,378 $7.96 Million
Q1 2022 May 16, 2022	SELL	$126.25 - $231.85 $2.33 Million - $4.29 Million	-18,487 Reduced 21.77%	66,442 $11.3 Million
Q4 2021 Feb 14, 2022	BUY	$216.64 - $362.52 $1.2 Million - $2.01 Million	5,555 Added 7.0%	84,929 $21.9 Million
Q3 2021 Nov 15, 2021	BUY	$205.93 - $447.23 $1.17 Million - $2.53 Million	5,658 Added 7.68%	79,374 $21.7 Million
Q2 2021 Aug 16, 2021	BUY	$113.32 - $241.49 $1.15 Million - $2.45 Million	10,134 Added 15.94%	73,716 $16.5 Million
Q1 2021 May 13, 2021	SELL	$85.73 - $119.5 $1.06 Million - $1.48 Million	-12,395 Reduced 16.31%	63,582 $6.94 Million
Q4 2020 Feb 09, 2021	BUY	$72.71 - $129.54 $4.7 Million - $8.37 Million	64,594 Added 567.46%	75,977 $6.19 Million
Q3 2020 Nov 05, 2020	BUY	$57.81 - $104.17 $111,457 - $200,839	1,928 Added 20.39%	11,383 $788,000
Q2 2020 Aug 13, 2020	BUY	$38.58 - $66.74 $352,003 - $608,935	9,124 Added 2756.5%	9,455 $631,000
Q1 2020 May 14, 2020	BUY	$28.55 - $92.0 $9,450 - $30,452	331 New	331 $20,000

Others Institutions Holding BNTX

# of Institutions

357

Shares Held

38.3M

Call Options Held

2.45M

Put Options Held

2.29M

View Full List

About BioNTech SE

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $29.3B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

More about BNTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Bio N Tech Se Transaction History